September, 2020 , Chemistry Today
Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and contract manufacturing
By: Simon Tyler
July, 2020 , Mantell Associates Network
Our CEO, Dr Ross Burn spoke to the Mantell Associates Network podcast about innovation during the COVID-19 pandemic.
By: Ross Burn
July, 2020 , Chemistry Today
Our Associate Principal Scientist, Dr Vargini Thangavadivale participated in the latest Chemistry Today panel discussion on catalysis
By: Vargini Thangavadivale
June, 2020 , The Medicine Maker
Our Chief Operating Officer, Dr Simon Tyler, recently spoke with The Medicine Maker to discuss the continuing impacts of COVID-19 on the pharmaceutical industry
June, 2020 , Chemicals Knowledge Hub
Our CEO, Dr Ross Burn talked to Chemicals Knowledge Hub TV about the origins of CatSci, our strategic shift and exponential growth over the past few years.
April, 2020 , CHEManager International
Our Head of Business Development for North America, Dr Jas Douville, recently spoke to CHEManager International about how a CRO can succeed in the global marketplace.
By: Jas Douville
April, 2020 , Chemicals Knowledge Hub
What is needed to drive effective process development? Understanding how to take a holistic approach to the technical, economic and regulatory factors underpinning your chemistry is crucial. Dr Alan Steven, Senior Principal Scientist at CatSci, explores.
By: Alan Steven
February, 2020 , Careers in Discovery
Our CEO, Dr Ross Burn spoke to the Careers in Discovery podcast about entrepreneurship, his career and CatSci's journey.
January, 2020 , Chemicals Knowledge Hub
Our Business Development Manager, Dr Jenny Wallis recently spoke to Chemicals Knowledge Hub about what it means to be a woman working in the pharmaceutical industry in the 21st century.
By: Jenny Wallis
October, 2019 , The Medicine Maker
Our Technical Director, Dr Jonathan Moseley, offers tips on how to manufacture your API in the right quantity, at the right cost, and in the right time frame - and not burn your factory down in the process!
By: Jonathan Moseley
September, 2019 , Chemistry Today
Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and manufacturing.
September, 2019 , CHEManager International
Our Business Development Manager, Dr Joao Madeira do O recently spoke to CHEManager International to discuss the current market for process research and development CROs like CatSci.
By: Joao Madeira do O
September, 2019 , Chemicals Knowledge Hub
Our Senior Scientist, Dr Joe Renny recently spoke to Chemicals Knowledge Hub to discuss the importance of exploiting green chemistry to produce perfect for purpose process chemistry solutions.
By: Joseph Renny
May, 2019 , C&EN
In C&EN, our COO Dr Simon Tyler discusses the importance of welcoming graduate chemists into our company and how we are dedicated to growing our team with bright, talented minds.
February, 2019 , The Medicine Maker
How can you ensure success when working with a CRO, such as CatSci, for process research and development? Hear from our COO, Dr Simon Tyler, in The Medicine Maker.
January, 2019 , Pharmaceutical Technology
Earlier this year, CatSci’s Dr. Jonathan Moseley spoke with Pharmaceutical Technology to discuss what makes our novel biocatalytic manufacturing process unique.
October, 2018 , CHEManager
CatSci’s Dr Ross Burn joins several other top industry experts to offer insight into what current market developments are most challenging for Pharma CDMOs and how they can tackle them.
September, 2018 , Chemical Week
Our CEO Dr Ross Burn talks to Michael Ravenscroft about the current trends in CRO outsourcing for the pharmaceutical market.
August, 2018 , Chemistry Today
In 2018, our CEO Dr Ross Burn took part in Chemistry Today’s Panel Discussion on Custom Synthesis and Contract Manufacturing.
August, 2018 , C&EN
Learn about our growth as a contract research organisation for the Pharma industry in this article, featuring our COO, Dr Simon Tyler.
July, 2018 , Chemicals Knowledge Hub
Dr Ross Burn, CEO and Dr Simon Tyler, COO at CatSci explain how process optimization can play an integral part in optimizing yield while reducing time and costs.
March, 2018 , Chemistry World
In a world that is racing ahead with new technologies, has the drug development process distanced itself from the patients it ultimately provides for? Hear more from our Chief Executive Officer, Dr. Ross Burn.
Keep up to date with the latest news from CatSci by signing up to our newsletter.
